Lpl Financial LLC Anavex Life Sciences Corp. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Lpl Financial LLC holds 68,855 shares of AVXL stock, worth $585,956. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,855

Previous 53,305 29.17%

Holding current value

$585,956

Previous $224,000 74.55%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$4.11 - $7.04 $63,910 - $109,472	15,550 Added 29.17%	68,855 $391,000
Q2 2024 Aug 07, 2024	SELL	$3.39 - $5.02 $19,577 - $28,990	-5,775 Reduced 9.77%	53,305 $224,000
Q1 2024 May 10, 2024	BUY	$4.55 - $6.75 $910 - $1,350	200 Added 0.34%	59,080 $300,000
Q4 2023 Feb 14, 2024	BUY	$5.04 - $9.95 $14,817 - $29,252	2,940 Added 5.26%	58,880 $548,000
Q3 2023 Nov 13, 2023	SELL	$6.55 - $9.37 $32,520 - $46,522	-4,965 Reduced 8.15%	55,940 $366,000
Q2 2023 Jul 31, 2023	BUY	$7.66 - $9.5 $89,928 - $111,530	11,740 Added 23.88%	60,905 $495,000
Q1 2023 May 10, 2023	BUY	$8.32 - $11.75 $45,968 - $64,918	5,525 Added 12.66%	49,165 $421,000
Q4 2022 Feb 07, 2023	BUY	$7.65 - $14.43 $29,070 - $54,834	3,800 Added 9.54%	43,640 $404,000
Q3 2022 Nov 14, 2022	BUY	$8.9 - $12.86 $21,449 - $30,992	2,410 Added 6.44%	39,840 $411,000
Q2 2022 Aug 12, 2022	BUY	$7.31 - $12.84 $81,762 - $143,615	11,185 Added 42.62%	37,430 $375,000
Q1 2022 May 16, 2022	BUY	$9.74 - $17.69 $99,835 - $181,322	10,250 Added 64.08%	26,245 $323,000
Q4 2021 Feb 14, 2022	SELL	$16.88 - $23.31 $79,217 - $109,393	-4,693 Reduced 22.68%	15,995 $277,000
Q3 2021 Nov 15, 2021	BUY	$16.82 - $25.75 $149,916 - $229,509	8,913 Added 75.69%	20,688 $371,000
Q2 2021 Aug 13, 2021	BUY	$10.16 - $28.86 $119,634 - $339,826	11,775 New	11,775 $269,000

Others Institutions Holding AVXL

# of Institutions

166

Shares Held

26.6M

Call Options Held

518K

Put Options Held

838K

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $663M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Anavex Life Sciences Corp. Transaction History